Phenylamino-substituted tricyclic derivatives for treatment of hyperproliferative diseases
    1.
    发明授权
    Phenylamino-substituted tricyclic derivatives for treatment of hyperproliferative diseases 失效
    用于治疗过度增生性疾病的苯基氨基取代的三环衍生物

    公开(公告)号:US06335344B1

    公开(公告)日:2002-01-01

    申请号:US09202738

    申请日:1999-09-29

    申请人: Rodney C. Schnur

    发明人: Rodney C. Schnur

    IPC分类号: C07D23970

    摘要: The present invention relates to compounds of the formula (I) and to pharmaceutically acceptable salts thereof, wherein R1-R4 and Z are as defined herein. The compounds of formula (I) are useful as antiproliferative agents. The invention further relates to pharmaceutical compositions and methods of treating hyperproliferative disorders such as cancer, using such compounds.

    摘要翻译: 本发明涉及式(I)化合物及其药学上可接受的盐,其中R 1 -R 4和Z如本文所定义。 式(I)的化合物可用作抗增殖剂。 本发明还涉及使用这些化合物治疗过度增殖性疾病如癌症的药物组合物和方法。

    Hypoglycemic 5-substituted oxazolidine 2,4-diones
    3.
    发明授权
    Hypoglycemic 5-substituted oxazolidine 2,4-diones 失效
    低血糖5-取代恶唑烷2,4-二酮

    公开(公告)号:US4689336A

    公开(公告)日:1987-08-25

    申请号:US783982

    申请日:1985-10-03

    申请人: Rodney C. Schnur

    发明人: Rodney C. Schnur

    摘要: Hypoglycemic 5-chromanyl, 2,3-dihydro-5-benzo[b]-furanyl, 5-pyridyl, 5-quinolyl, 5-pyrrolyl, 5-indolyl, 5-thiazolyl, 5-oxazolyl, 5-isothiazolyl and 5-isoxazolyl oxazolidine-2,4-diones and the pharmaceutically-acceptable salts thereof; certain 3-acylated derivatives thereof; a method of treating hyperglycemic animals therewith; and intermediates useful in the preparation of said compounds.

    摘要翻译: 5-低级血清5-苯并二氢吡喃基,2,3-二氢-5-苯并[b]呋喃基,5-吡啶基,5-喹啉基,5-吡咯基,5-吲哚基,5-噻唑基,5-恶唑基,5-异噻唑基和5- 异恶唑基恶唑烷-2,4-二酮及其药学上可接受的盐; 某些3-酰化衍生物; 一种治疗高血糖动物的方法; 和可用于制备所述化合物的中间体。

    Novel spiro-oxazolidinediones
    7.
    发明授权
    Novel spiro-oxazolidinediones 失效
    新型螺恶唑烷二酮类

    公开(公告)号:US4226875A

    公开(公告)日:1980-10-07

    申请号:US26615

    申请日:1979-04-02

    申请人: Rodney C. Schnur

    发明人: Rodney C. Schnur

    摘要: Novel spiro-oxazolidinediones useful as aldose reductase inhibitors and as therapeutic agents for the treatment of chronic diabetic complications are disclosed. Pharmaceutical compositions containing the novel compounds and a method of treating chronic diabetic complications are also disclosed.

    摘要翻译: 公开了可用作醛糖还原酶抑制剂和用作治疗慢性糖尿病并发症的治疗剂的新型螺恶唑烷二酮类。 还公开了含有新化合物的药物组合物和治疗慢性糖尿病并发症的方法。

    Spiro-quinolone hydantoins
    8.
    发明授权
    Spiro-quinolone hydantoins 失效
    螺 - 喹诺酮乙内酰脲

    公开(公告)号:US4193996A

    公开(公告)日:1980-03-18

    申请号:US26990

    申请日:1979-04-04

    申请人: Rodney C. Schnur

    发明人: Rodney C. Schnur

    CPC分类号: C07D215/227 C07D455/04

    摘要: Novel spiro-quinolone hydantoin derivatives useful as aldose reductase inhibitors and as therapeutic agents for the treatment of chronic diabetic complications are disclosed. Pharmaceutical compositions containing the novel compounds and a method of treating chronic diabetic complications are also disclosed. Preferred compounds include spiro[2,3-dihydro-1H,5H-benzo[ij]quinolizin[1,4']imidazolidin]-2',5,5.dbd.-trione and 10-chloro-spiro[2,3-dihydro-1H,5H-benzo[ij]quinolizin[1,4']imidazolidin]-2',5,5'-trione.

    摘要翻译: 公开了用作醛糖还原酶抑制剂和用作治疗慢性糖尿病并发症的治疗剂的新型螺 - 喹诺酮乙内酰脲衍生物。 还公开了含有新化合物的药物组合物和治疗慢性糖尿病并发症的方法。 优选的化合物包括螺[2,3-二氢-1H,5H-苯并[i]喹嗪酮[1,4']咪唑烷] -2',5,5 =三酮和10-氯 - 螺[2,3-二氢 -1H,5H-苯并[ij]喹嗪酮[1,4']咪唑烷n] -2',5,5'-三酮。